Close this section Close this section Expand this section Previous Next caret-right-red Open menu Search loading-icon

A New Website is Coming Soon: We’re working on an enhanced digital experience to serve you better. Starting October 21, you’ll have a new website to connect with us. Don’t worry, you can still access this website until December 8. Check back for more updates.

Are you a
This form enables site users to switch sudience context to see different content on the site
Back to resource center

Drug Labeling Updates – September 2025

Back to resource center

To help ensure patient safety, a Coram clinician may notify a patient and/or their physician of these labeling updates when appropriate.

Drug Name Active Ingredient Supplement Date Database Updated
INFLECTRA INFLIXIMAB-DYYB 09/03/2025 09/05/2025
RYBREVANT AMIVANTAMAB-VMJW 09/03/2025 09/08/2025
SKYRIZI RISANKIZUMAB-RZAA 09/03/2025 09/05/2025
SKYRIZI RISANKIZUMAB-RZAA 09/03/2025 09/05/2025
VIGAFYDE VIGABATRIN 09/03/2025 09/05/2025
GATTEX KIT TEDUGLUTIDE RECOMBINANT 09/05/2025 09/10/2025
SUSVIMO RANIBIZUMAB 09/05/2025 09/10/2025
EPKINLY EPCORITAMAB-BYSP 09/11/2025 09/15/2025
LUPRON DEPOT LEUPROLIDE ACETATE 09/10/2025 09/12/2025
LUPRON DEPOT LEUPROLIDE ACETATE 09/10/2025 09/12/2025
LUPRON DEPOT LEUPROLIDE ACETATE 09/10/2025 09/12/2025
RETIN-A MICRO TRETINOIN 09/10/2025 09/12/2025

 

Reference: Drug Safety-related Labeling Changes (SrLC) (fda.gov)

This article contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with Coram.